BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 14961168)

  • 1. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
    Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
    Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
    Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
    Eur Heart J; 1999 Nov; 20(22):1657-66. PubMed ID: 10543929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
    Linder R; Oldgren J; Egberg N; Grip L; Larson G; Siegbahn A; Wallentin L
    Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
    Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
    Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation activity and clinical outcome in unstable coronary artery disease.
    Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after surgery for acute coronary syndromes in relation to perioperative troponin T release and angina class - a prospective study in 200 patients.
    Bjessmo S; Svenarud P; Tran PK
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):148-52. PubMed ID: 19330751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease.
    Ernofsson M; Strekerud F; Toss H; Abildgaard U; Wallentin L; Siegbahn A
    Thromb Haemost; 1998 Mar; 79(3):491-4. PubMed ID: 9531028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cardiac troponin T and procoagulant activity in unstable angina.
    Giannitsis E; Bardorff MM; Schweikart S; Wiegand U; Kampmann M; Katus HA
    Thromb Haemost; 2000 Feb; 83(2):224-8. PubMed ID: 10739377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease.
    Oldgren J; Fellenius C; Boman K; Jansson JH; Nilsson TK; Wallentin L; Siegbahn A
    J Intern Med; 2005 Nov; 258(5):420-7. PubMed ID: 16238677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention.
    Mueller C; Neumann FJ; Perruchoud AP; Zeller T; Buettner HJ
    Am J Med; 2004 Dec; 117(12):897-902. PubMed ID: 15629727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J; Johnston N; Siegbahn A
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
    Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Peterson ED; Pollack CV; Newby LK; Li Y; Christenson RH; Peacock WF; Fesmire FM; Diercks D; Kirk JD; Smith SC; Ohman EM; Gibler WB;
    Ann Emerg Med; 2005 Apr; 45(4):355-62. PubMed ID: 15795713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice].
    James S; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Wallentin L
    Lakartidningen; 2004 Apr; 101(17):1514-9, 1521-2. PubMed ID: 15150954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should troponin-T be assessed during exercise stress testing in patients with stable angina pectoris?
    Eryol NK; Başar E; Ozdoğru I; Ciçek Y; Abaci A; Oğuzhan A; Topsakal R; Cetin S
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):132-7. PubMed ID: 12134538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.